Best Income Stocks to Buy for April 10th

05:30am, Thursday, 10'th Apr 2025
ALX, TAP and TEF made it to the Zacks Rank #1 (Strong Buy) income stocks list on April 10, 2025.
The recent sell-off has increased the temptation to reach for some of the many high-yield REITs, but beware of "mousetrap" REITs with unsustainable dividends. Dividend safety is crucial; a cut can lea

New Strong Buy Stocks for April 3rd

07:40am, Thursday, 03'rd Apr 2025
NATL, BGC, NPSNY, ALX and VEEV have been added to the Zacks Rank #1 (Strong Buy) List on April 3, 2025.

Best Income Stocks to Buy for April 3rd

03:55am, Thursday, 03'rd Apr 2025
ALX, AVGO and BNPQY made it to the Zacks Rank #1 (Strong Buy) income stocks list on April 3, 2025.
Here is how Alexander's (ALX) and Banco Bilbao (BBVA) have performed compared to their sector so far this year.
Alexander's (ALX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Best Income Stocks to Buy for March 28th

04:10am, Friday, 28'th Mar 2025
ALX, HAFC and FFBC made it to the Zacks Rank #1 (Strong Buy) income stocks list on March 28, 2025.
Magnifying the trend of positive earnings estimate revisions for these highly ranked stocks is their attractive dividends, which are reassuring as investors hope the broader market will continue to st

Best Income Stocks to Buy for March 25th

05:36am, Tuesday, 25'th Mar 2025
ALX, HAFC and HBNC made it to the Zacks Rank #1 (Strong Buy) income stocks list on March 25, 2025.
Here is how Alexander's (ALX) and Banco Bilbao (BBVA) have performed compared to their sector so far this year.

Best Income Stocks to Buy for March 13th

05:31am, Thursday, 13'th Mar 2025
ALX, HAFC and FHB made it to the Zacks Rank #1 (Strong Buy) income stocks list on March 13, 2025.

Best Income Stocks to Buy for March 11th

05:26am, Tuesday, 11'th Mar 2025
ALX, VLY and HAFC made it to the Zacks Rank #1 (Strong Buy) income stocks list on March 11, 2025.
– Presented positive updated data from ASPEN-06 Phase 2 trial demonstrating evorpacept generates strong response and durable clinical benefit in patients with HER2-positive gastric cancer in an oral
Event to include updates on ongoing evorpacept clinical development program and introduction of clinical trials in breast and colorectal cancers Advancing novel EGFR-targeted antibody-drug conjugate (
SOUTH SAN FRANCISCO, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing th
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE